54 results
Page 3 of 3
6-K
EX-99.1
rquitgj
11 Jun 19
Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China
7:00am
424B2
scxoetb4 9bzk
6 May 19
Prospectus for primary offering
6:04am
424B5
exi5q3u8u
1 May 19
Prospectus supplement for primary offering
5:26pm
F-3ASR
x46vzpeh80
29 Mar 19
Automatic shelf registration (foreign)
5:13pm
424B4
nq2cnt2stiv7 vn
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
EX-4.17
ug2l4g48t5tskzda z3
30 Apr 18
Annual report (foreign)
9:07am
20-F
ee6xa ml0
30 Apr 18
Annual report (foreign)
9:07am
20-F
EX-4.15
li7b 3sp06
30 Apr 18
Annual report (foreign)
9:07am